Cabka (CABKA) Q3 2024 TU earnings summary

Executive summary

• Q3 2024 sales rose 8% year-over-year to €42.4 million, signaling recovery after a weak start to the year.

• Year-to-date sales reached €135 million, still 6% below the prior year due to a challenging Q1.

• RTP portfolio in Europe and the US grew 16% and 12% year-to-date, respectively.

Financial highlights

• Q3 sales: €42.4 million, up from €39.3 million in Q3 2023.

• Year-to-date sales: €135 million, down from €144 million in 2023.

• Contract Manufacturing and non-strategic sales declined 45% year-to-date, a €9.9 million drop.

Outlook and guidance

• On track to meet full-year 2024 sales guidance of €180–185 million.

• EBITDA margin expected in the 13–15% range for 2024.

• Focused on completing Q4 and building growth for 2025.